Synspira Therapeutics
Dr. Shenda Baker serves as a chief scientific officer of Synspira Therapeutics. Dr. Baker has more than 25 years of experience in polymer chemistry and materials science and in leading, funding, and directing scientific research and development. She has extensive experience managing project execution, external consultants and advisors, and business development efforts. She is President and COO of Synedgen Inc. Previously, Dr. Baker served as President of BioSTAR West, and as the lead scientific advisor to Hawaii Chitopure and Professor of Chemistry at Harvey Mudd College. Dr. Baker served on the Board of Directors of the Materials Research Society and has served on advisory boards with the National Institutes of Health, National Science Foundation, and the Department of Energy. Dr. Baker is a member of the American Chemical Society and the Materials Research Society and currently serves on the Advisory Council of the National Institute of Dental and Craniofacial Research of the NIH. She is a co-inventor on all Synspira technology.
This person is not in any offices
Synspira Therapeutics
Synspira Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to significantly improving the lives of people with cystic fibrosis (CF) and other rare diseases.